Lunai Bioworks Inc. 8-K/A

What Happened Lunai Bioworks Inc. (LNAI) filed an amendment to its Form 8-K on May 11, 2026 to report that it received an additional staff determination letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC on April 28, 2026 concerning compliance with Nasdaq Listing Rule 5550(b)(2). The amendment also notes that the previously disclosed solicitation materials and certain related disclosures in the Original Report are no longer applicable because the Special Meeting of stockholders has been held and the proposals submitted thereat have been acted upon.

Key Details

• Date of Nasdaq letter: April 28, 2026.
• Filing date of this amendment (Form 8-K/A): May 11, 2026.
• The amendment withdraws solicitation-related disclosures in the Original Report under the captions “The Special Meeting and the Proposals Being Voted On,” “Additional Information and Where to Find It” and “Participants in the Solicitation.”
• The company says the final voting results from the Special Meeting will be reported in a separate Form 8-K.

Why It Matters This filing updates investors that Nasdaq’s Listing Qualifications Staff has issued an additional determination regarding the company’s compliance with a Nasdaq listing rule, and that the related stockholder special meeting has concluded. Compliance determinations and related stockholder actions can affect a company’s continued listing status on Nasdaq, so investors should watch for the separate 8-K that will disclose the final vote results and any subsequent company disclosures.